Economic burden of multiple sclerosis: a cross-sectional study in Iran.
Mehdi RezaeeKhosro KeshavarzSadegh IzadiAbdosaleh JafariRamin RavangardPublished in: Health economics review (2022)
Considering the findings of this study and in order to reduce the burden of the disease, the following suggestions are presented: providing necessary facilities for the production of MS drugs in the country; proper and equitable distribution of neurologists; expanding the provision of home care services; and using the technologies related to the Internet, including WhatsApp, to follow up the MS patients' treatment.
Keyphrases
- multiple sclerosis
- end stage renal disease
- mass spectrometry
- ms ms
- ejection fraction
- chronic kidney disease
- healthcare
- newly diagnosed
- primary care
- risk factors
- palliative care
- peritoneal dialysis
- white matter
- prognostic factors
- mental health
- patient reported outcomes
- health information
- drug induced
- replacement therapy
- patient reported